Oxford Immunotec appoints Frank Vandeputte
Published on: 04/02/10
Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing.
He was formerly VP, Europe for medical technology company CryoCath Technologies, where he was responsible for developing and implementing strategic and operational business plans.
He also led the European team though the company’s acquisition by Medtronic in November 2008.
With over 20 years experience in the medical device industry, Frank has held senior management positions with leading companies, including Baxter International, Becton Dickinson and Guidant Corporation.
The company has also added Dr Peter Klemm, president and chief executive of Predictive Biosciences, as a non-executive director.